VERSES AI’s Final Countdown: Trading Halted, Top Scientists Flee, and a 90-Day Window to Survive
28.06.2026 - 16:23:01 | boerse-global.de
The clock is ticking for VERSES AI. After Cboe Canada suspended trading in the company’s shares on June 19, a 90-day period is now underway that will determine whether the stock ever trades again. The company must either find a buyer, secure a merger partner, or present a credible restructuring plan to the exchange by mid-September. VERSES AI itself has made no secret of the possibility that this process could fail.
The gravity of the situation became clear on June 18, when the board announced a complete halt to all artificial intelligence research and development activities. The decision, driven by a lack of capital, adverse market conditions, and a commercialization path deemed too distant, effectively gutted the company’s core business. Research, development, and related expenses were stopped immediately, leaving VERSES AI as little more than a corporate shell.
The financial numbers underscore the collapse. For fiscal year 2026, VERSES AI reported a net loss of approximately $43 million on revenue of just $155,000. Its gross margin stood at negative 307%. Attempts to raise capital, pursue a merger, or sell assets all failed over a four-month period, according to interim CEO David T. Scott. The company now says it is exploring “strategic alternatives” but has not identified a specific new business model.
Meanwhile, the executive suite has emptied. On June 27, president and COO James Hendrickson and CTO Hari Thiruvengada resigned, citing fundamental conflicts with the board, including unpaid employee wages. More damaging still, Karl Friston, the renowned neuroscientist who served as chief science officer and whose work on active inference formed the theoretical backbone of the “Genius” platform, announced his departure. Market observers view Friston’s exit as the final loss of scientific credibility. Earlier in the year, CEO Gabriel René stepped down in February, followed by the departures of co-founder Dan Mapes and CFO Kevin Wilson. The workforce had already been cut by roughly half, and some executives had temporarily deferred parts of their salaries.
Should investors sell immediately? Or is it worth buying VERSES AI?
The financial pressure intensified when a $10 million convertible note from Abu Dhabi’s G42 investment firm came due on June 20, just days after the trading suspension. Issued in June 2024 with a 10% annual interest rate, the instrument was converted into equity, according to VERSES AI. Whether that conversion alleviated or added to the balance sheet strain remains unclear.
Two recent business deals have also unravelled. A licensing agreement with Prodigii AI, signed only in April 2026, was terminated. The deal had promised an initial payment of $350,000 and quarterly payments of $125,000 over ten years. VERSES AI also dissolved a partnership with an unnamed global investment house, which management had previously touted as central to integrating the Genius platform into institutional risk management.
The stock market reaction was brutal. In the five trading days leading up to the suspension, the share price collapsed from C$0.67 to C$0.38, a 43% slide. Market capitalization stood at roughly C$3.74 million at that point — a far cry from the 52-week high of C$24.48. On the Frankfurt exchange, the last trade was at €0.202. Over the past twelve months, the stock has lost more than 96% of its value.
VERSES AI at a turning point? This analysis reveals what investors need to know now.
With trading frozen, the core business shuttered, and the leadership ranks decimated, VERSES AI faces an uphill battle to meet Cboe Canada’s requirements within 90 days. The company itself describes the outcome as uncertain, leaving shareholders with little more than a waiting game.
Ad
VERSES AI Stock: New Analysis - 28 June
Fresh VERSES AI information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
